Question 1

FDA 批准了 Johnson & Johnson 销售什么？

Accepted Answer

The FDA granted De Novo marketing authorization for the OTTAVA Robotic Surgical System, cleared for ten general surgery procedures in the upper abdomen, including cholecystectomy, appendectomy, gastric sleeve, and Roux-en-Y gastric bypass.

Question 2

OTTAVA 与其他手术机器人有何不同？

Accepted Answer

According to Johnson & Johnson, OTTAVA integrates its four robotic arms directly into the operating table rather than using carts or booms, a design the company says occupies 30 to 50 percent less space than traditional systems.

Question 3

医院何时能使用 OTTAVA？

Accepted Answer

Johnson & Johnson said it will launch the system commercially with select US customers first, while pursuing additional approved uses and clearance in other countries; a US clinical trial for inguinal hernia repair is ongoing.

Johnson & Johnson

强生公司赢得 FDA 对其机器人手术设备的授权

一份犀利简报。
每天。

Johnson & Johnson

强生公司赢得 FDA 对其机器人手术设备的授权

一份犀利简报。每天。

一份犀利简报。
每天。